The human epidermal growth factor ELISA (human EGF) test quantifies human EGF in serum, plasma, cell culture supernatants or other human body fluids. The dosage will recognize exclusively the EGF...
The human epidermal growth factor ELISA (human EGF) test quantifies human EGF in serum, plasma, cell culture supernatants or other human body fluids. The dosage will only recognize natural and recombinant human EGW. Principle of the L-ELISA solid phase sandwich method for human EGF (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples or controls are then added to these wells and are linked to immobilized antibodies (capture). The sandwich is formed by binding the second antibody (detector) to the target on a different epitope from the capture antibody. An antibody conjugated with the enzyme binds the formed sandwich. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
L的EGF belongs to a family of growth factors that bind to the 170 kDa EGF receptor. EGF receptor ligands are synthesized as type I transmembrane proteins of 130 kDa with an N-terminal end extension called EGF module and fragment one at C-terminal end, also known as cytoplasmic tail. L的EGF includes nine d的EGF motifs; only the one adjacent to the cell membrane is functional as a binding domain of d的EGF receptors. Due to proteolytic cleavage, a soluble growth factor of 6 kDa containing the EGF module is released into extracellular space (′excretion d的ectodomain′). L-EGF can be detected in most body fluids; the concentration is particularly high in plasma, urine, saliva and milk. Blisters and cells in various organs such as brain, kidney, salivary gland and stomach release EGF. As a mitogen for endothelial cells, EGF also affects l的angiogenesis and plays a role in wound healing processes. Blocking the release of d的EGF receptor ligands inhibits growth and migration into several d的EGF receptor-dependent cell lines and significantly delays wound reepitheliization due to altered keratinocyte migration. Overexpression of one or more receptors and/or ligands is a characteristic of the majority of human carcinomas and epithelial cancers.
Sensitivity
Sensitivity of the dosage: 0.26 pg/ml.
Measurement range
Dose range: 3.91-250 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of variation between doses 3.5%, interdose 4.1%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15581587 |
| Specifications |
| Accession number | P01133 |
| Dose range | 3.91-250 pg/ml |
| Sensitivity of the dosage | 0.26 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 1950 |
| Gene symbol(s) | HOMG4,URG |
| Coefficient of inter-dose variation | 4.1% |
| Coefficient of intra-dose variation | 3.5% |
| Contents of kits | 96-well pre-coated microplate, Biotinylated detection antibody, Sample diluent, Sample diluent, lyophilized, Standard curve strips, Wash buffer concentrate, Stop solution, 10x lysis pad, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 128 Tests |
| Regulatory status | RUO |
| Synonym | Epidermal growth factor, urogastrone |
| Target | Human |
| Test time | 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; Serum, 50 μl; Supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 3 h 30 min |
Origin and customs
| Manufacturer ref. | BMS2070INST |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.